alexa KIOM-CRC#140(FFWE) Attenuates Oxaliplatin-induced Neurotoxicity In Vitro And In Vivo Model
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

14th World Cancer & Anti-Cancer Therapy Convention
November 21-23, 2016 Dubai, UAE

Jin-Mu Yi, You Jin Lee, Ok-Sun Bang and No Soo Kim
Korea Institute of Oriental Medicine, South Korea
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.C1.094
Oxaliplatin can induce peripheral neuropathy (OXIPN) as an adverse side effect in cancer patients. Until now, no effective preventive or therapeutic drug has been developed; therefore, the dose-limiting factor of OXIPN is still and obstacle in the use of oxaliplatin to treat cancer patients. We tried to find effective materials to relieve oxaliplatin-mediated neurotoxicity using a library of medicinal herb extracts that have been traditionally used. We screened extracts with biological activities to relieve oxaliplatin-mediated neurotoxicity using in vitro cell-based assays which employed the nerve growth factor (NGF)-induced neurite growth from rat pheochromocytoma PC12 cells, and found that the aqueous extract of FFWE could effectively recover the cells from the neurotoxicity of oxaliplatin. The protective effect of FFWE on oxaliplatin-induced neurotoxicity was evaluated in vitro by quantifying nerve growth factor (NGF)-induced neurite outgrowth in PC12 treated with a combination of oxaliplatin and FFWE. The neuroprotective potential of FFWE was further confirmed by measuring the changes in nociceptive sensitivities to external mechanical stimuli in neuropathic animals induced by oxaliplatin. In the present study, we report for the first time that the FFWE can attenuate the oxaliplatin-induced neurotoxicity in vitro and in vivo models. FFWE may be considered as a good starting material to develop a novel therapeutic agent targeting OXIPN.

Jin-Mu Yi has his expertise in evaluation of anti-cancer and anti-CIPN activity using in vitro and in vivo model.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version